More Globe Newswire

View Older Stories View Newer Stories

Feb 25, 2025 07:05AM Venus Concept Announces Senior Management Changes
Feb 25, 2025 07:05AM CorVel Earns 2025 Great Place To Work Certification™
Feb 25, 2025 07:05AM Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences
Feb 25, 2025 07:03AM Gilat to Invest up to $3.5 Million in Disruptive ESA Based Drone Detection Startup Crosense
Feb 25, 2025 07:00AM Helium Evolution Provides Significant Update on Production Facilities, Preliminary Results of 5-30 Well, and Operations Update
Feb 25, 2025 07:00AM LAVA Announces Evaluation of Strategic Options
Feb 25, 2025 07:00AM Nusano to Present at B. Riley Precision Oncology & Radiopharma Conference
Feb 25, 2025 07:00AM LGI Homes, Inc. Reports Fourth Quarter and Full Year 2024 Results and Issues Guidance for 2025
Feb 25, 2025 07:01AM Xometry Reports Fourth Quarter and Full Year 2024 Results
Feb 25, 2025 07:00AM Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Feb 25, 2025 07:00AM Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
Feb 25, 2025 07:00AM Aura Biosciences to Participate in Upcoming Investor Conferences
Feb 25, 2025 07:00AM EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
Feb 25, 2025 07:00AM PEL 83 Second Campaign – Update 5 Additional Discoveries at Mopane 3-X
Feb 25, 2025 07:00AM Medicenna Reports MDNA11’s Compelling Anti-Cancer Activity is Associated with Significant Expansion of ‘Stem-Like’ Cancer Fighting Immune Cells at the Inaugural AACR-Immuno-Oncology Conference a
Feb 25, 2025 07:00AM Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Feb 25, 2025 07:00AM Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Feb 25, 2025 07:00AM Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
Feb 25, 2025 07:00AM Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2024
Feb 25, 2025 07:00AM Ocular Therapeutix™ to Present at Two Investor Conferences in March
Feb 25, 2025 07:00AM RYVYL Announces 2024 Preliminary Revenue of $56.0 Million and Introduces 2025 Revenue Guidance of $80 Million to $90 Million
Feb 25, 2025 07:00AM U.S. Department of Defense’s Defense Innovation Unit Adds Mobilicom’s SkyHopper PRO Micro to Blue UAS Framework
Feb 25, 2025 07:00AM CECO Environmental Reports Fourth Quarter and Full Year 2024 Results
Feb 25, 2025 07:00AM CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
Feb 25, 2025 07:00AM Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
Feb 25, 2025 07:00AM Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO
Feb 25, 2025 07:00AM Bitdeer Reports Unaudited Financial Results for the Fourth Quarter and Full Year of 2024
Feb 25, 2025 07:00AM LGI Homes, Inc. Reports Fourth Quarter and Full Year 2024 Results and Issues Guidance for 2025
Feb 25, 2025 07:00AM Cipher Mining Provides Fourth Quarter and Full Year 2024 Business Update
Feb 25, 2025 07:00AM Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements
Feb 25, 2025 07:00AM ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
Feb 25, 2025 07:00AM GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement
Feb 25, 2025 07:00AM ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease
Feb 25, 2025 07:00AM Climb Bio to Present at Upcoming Investor Conferences
Feb 25, 2025 07:00AM Plug To Announce 2024 Fourth Quarter and Year-End Results
Feb 25, 2025 07:00AM Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Feb 25, 2025 07:00AM Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts
Feb 25, 2025 07:00AM Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
Feb 25, 2025 07:00AM Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
Feb 25, 2025 07:00AM Stantec announces record 2024 earnings, increases dividend by 7%, achieves all-time record backlog of $7.8 billion, and provides 2025 outlook
Feb 25, 2025 07:00AM Macerich To Present at Citi’s 2025 30th Annual Global Property CEO Conference
Feb 25, 2025 07:00AM Regenx Welcomes New Board Member and Changes Auditor
Feb 25, 2025 07:00AM Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Feb 25, 2025 07:00AM Syndax Announces Participation in March Investor Conferences
Feb 25, 2025 07:00AM OTC Markets Group Welcomes PINEWOOD TECHNOLOGIES GROUP PLC to OTCQX
Feb 25, 2025 06:55AM ChampionX Announces Definitive Agreement to Sell US Synthetic Corporation
Feb 25, 2025 06:50AM Dillard’s, Inc. Reports Fourth Quarter and Fiscal Year Results
Feb 25, 2025 06:50AM TransUnion to Present at the 2025 RBC Capital Markets Global Financial Institutions Conference
Feb 25, 2025 06:45AM TopBuild Reports Fourth Quarter and Year-End 2024 Results, Provides 2025 Outlook and Announces New $1 Billion Share Repurchase Authorization 
Feb 25, 2025 06:45AM Castellum, Inc. Announces Its GTMR Subsidiary Has Been Selected as a SCI MAC Vendor
View Newer Stories View Older Stories